Madan Jagasia

23.1k total citations · 2 hit papers
251 papers, 7.2k citations indexed

About

Madan Jagasia is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Madan Jagasia has authored 251 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Hematology, 85 papers in Oncology and 49 papers in Immunology. Recurrent topics in Madan Jagasia's work include Hematopoietic Stem Cell Transplantation (136 papers), Acute Lymphoblastic Leukemia research (40 papers) and Acute Myeloid Leukemia Research (34 papers). Madan Jagasia is often cited by papers focused on Hematopoietic Stem Cell Transplantation (136 papers), Acute Lymphoblastic Leukemia research (40 papers) and Acute Myeloid Leukemia Research (34 papers). Madan Jagasia collaborates with scholars based in United States, Spain and Canada. Madan Jagasia's co-authors include Stephanie J. Lee, Corey Cutler, Mary E.D. Flowers, Joseph Pidala, Bipin N. Savani, Paul J. Martin, Steven Z. Pavletic, Mukta Arora, Jeanne Palmer and Daniel J. Weisdorf and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Madan Jagasia

240 papers receiving 7.1k citations

Hit Papers

The Biology of Chronic Graft-versus-Host Disease: A Task ... 2015 2026 2018 2022 2016 2015 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease
    2016 283 citations Kenneth R. Cooke, Leo Luznik et al. Biology of Blood and Marrow Transplantation profile →
  2. Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report
    2015 280 citations Stephanie J. Lee, Madan Jagasia et al. Biology of Blood and Marrow Transplantation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madan Jagasia United States 43 5.1k 1.9k 1.6k 1.6k 1.3k 251 7.2k
Frédéric Baron Belgium 40 5.2k 1.0× 1.9k 1.0× 1.7k 1.0× 1.4k 0.9× 1.4k 1.1× 220 7.2k
Karen K. Ballen United States 45 5.8k 1.1× 1.9k 1.0× 2.1k 1.3× 1.8k 1.1× 1.9k 1.5× 234 8.1k
Enric Carreras Spain 52 5.1k 1.0× 1.6k 0.8× 2.2k 1.4× 1.2k 0.7× 1.4k 1.1× 255 8.4k
Kirk R. Schultz Canada 45 5.0k 1.0× 1.8k 0.9× 1.3k 0.8× 2.6k 1.6× 1.1k 0.8× 214 7.4k
Marcelo C. Pasquini United States 46 5.3k 1.0× 1.7k 0.9× 2.3k 1.4× 1.6k 1.0× 919 0.7× 246 7.6k
Christopher Bredeson Canada 46 4.5k 0.9× 1.0k 0.5× 1.9k 1.2× 1.6k 1.0× 1.3k 1.0× 170 6.7k
Yoshiko Atsuta Japan 42 5.1k 1.0× 1.7k 0.9× 1.6k 1.0× 1.8k 1.1× 881 0.7× 451 6.6k
Daniel R. Couriel United States 45 4.7k 0.9× 1.9k 1.0× 1.8k 1.1× 1.1k 0.7× 895 0.7× 155 6.6k
Dietrich W. Beelen Germany 45 5.2k 1.0× 2.0k 1.0× 1.5k 0.9× 1.4k 0.9× 1.4k 1.1× 322 7.4k
Claudio G. Brunstein United States 44 5.9k 1.2× 3.1k 1.6× 2.3k 1.4× 1.3k 0.8× 1.8k 1.4× 247 8.0k

Countries citing papers authored by Madan Jagasia

Since Specialization
Citations

This map shows the geographic impact of Madan Jagasia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madan Jagasia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madan Jagasia more than expected).

Fields of papers citing papers by Madan Jagasia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madan Jagasia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madan Jagasia. The network helps show where Madan Jagasia may publish in the future.

Co-authorship network of co-authors of Madan Jagasia

This figure shows the co-authorship network connecting the top 25 collaborators of Madan Jagasia. A scholar is included among the top collaborators of Madan Jagasia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madan Jagasia. Madan Jagasia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amaria, Rodabe N., Krishna V. Komanduri, Adam J. Schoenfeld, et al.. (2024). Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation. Cytotherapy. 27(7). 864–873. 2 indexed citations
2.
Amaria, Rodabe N., Jennifer L. McQuade, Michael A. Davies, et al.. (2024). OBX-115, an interleukin 2 (IL2)-sparing engineered tumor-infiltrating lymphocyte (TIL) cell therapy, in patients (pts) with immune checkpoint inhibitor (ICI)-resistant unresectable or metastatic melanoma.. Journal of Clinical Oncology. 42(16_suppl). 9515–9515. 17 indexed citations
3.
Olson, Daniel J., Brian Gastman, Madan Jagasia, et al.. (2023). HSR23-110: Immune Checkpoint Inhibitor (ICI) Treatment After Progression on Anti–PD-1 Therapy in Advanced Melanoma: A Systematic Review of the Literature. Journal of the National Comprehensive Cancer Network. 21(3.5). HSR23–110.
4.
Wells, Adrian, Georgina V. Long, Richard A. Scolyer, et al.. (2022). Successful Manufacturing of Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy from Cryopreserved Melanoma Tumors Shipped from Australia. Transplantation and Cellular Therapy. 28(3). S226–S227. 1 indexed citations
5.
Cutler, Corey, Stephanie J. Lee, Sally Arai, et al.. (2021). Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD) after 2 or More Prior Lines of Therapy: The Rockstar Study (KD025-213). Transplantation and Cellular Therapy. 27(3). S7–S8. 3 indexed citations
6.
Koning, Coco de, Weiyang Tao, Mitchell E. Horwitz, et al.. (2021). Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation. Bone Marrow Transplantation. 56(11). 2826–2833. 3 indexed citations
7.
Chen, Fuyao, et al.. (2021). Optimal Biomechanical Parameters for Measuring Sclerotic Chronic Graft-Versus-Host Disease. CORROSION. 1(3). 100037–100037. 8 indexed citations
8.
Byrne, Michael, et al.. (2020). 434 Association of skin response in erythema and sclerosis with survival in chronic graft-versus-host disease. Journal of Investigative Dermatology. 140(7). S57–S57. 2 indexed citations
9.
Schroeder, Mark A., H. Jean Khoury, Madan Jagasia, et al.. (2020). A phase 1 trial of itacitinib, a selective JAK1 inhibitor, in patients with acute graft-versus-host disease. Blood Advances. 4(8). 1656–1669. 72 indexed citations
10.
Epperla, Narendranath, Kwang Woo Ahn, Philippe Armand, et al.. (2017). Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma. Biology of Blood and Marrow Transplantation. 24(1). 78–85. 7 indexed citations
11.
Cooke, Kenneth R., Leo Luznik, Stefanie Sarantopoulos, et al.. (2016). The Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(2). 211–234. 283 indexed citations breakdown →
12.
Yu, Jeffrey, Barry E. Storer, Kushi Kushekhar, et al.. (2016). Biomarker Panel for Chronic Graft-Versus-Host Disease. Journal of Clinical Oncology. 34(22). 2583–2590. 89 indexed citations
13.
Kennedy, Vanessa E., Bipin N. Savani, John P. Greer, et al.. (2016). Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies. Biology of Blood and Marrow Transplantation. 22(10). 1801–1807. 7 indexed citations
14.
Paczesny, Sophie, Frances T. Hakim, Joseph Pidala, et al.. (2015). National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease: III. The 2014 Biomarker Working Group Report. PMC. 1 indexed citations
15.
O’Brien, Susan, Camille N. Abboud, Mojtaba Akhtari, et al.. (2012). Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 10(1). 64–110. 20 indexed citations
16.
McClune, Brian, Daniel J. Weisdorf, Tanya L. Pedersen, et al.. (2010). Effect of Age on Outcome of Reduced-Intensity Hematopoietic Cell Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission or With Myelodysplastic Syndrome. Journal of Clinical Oncology. 28(11). 1878–1887. 338 indexed citations
17.
O’Brien, Susan, Ellin Berman, Hossein Borghaei, et al.. (2009). Chronic Myelogenous Leukemia. Journal of the National Comprehensive Cancer Network. 7(9). 984–1023. 175 indexed citations
18.
Jagasia, Madan, Bipin N. Savani, George P. Stricklin, et al.. (2009). Classic and Overlap Chronic Graft-versus-Host Disease (cGVHD) Is Associated with Superior Outcome after Extracorporeal Photopheresis (ECP). Biology of Blood and Marrow Transplantation. 15(10). 1288–1295. 54 indexed citations
19.
Briggs, Robert C., Keith Shults, Madan Jagasia, et al.. (2006). Dysregulated Human Myeloid Nuclear Differentiation Antigen Expression in Myelodysplastic Syndromes: Evidence for a Role in Apoptosis. Cancer Research. 66(9). 4645–4651. 36 indexed citations
20.
Jagasia, Madan, John P. Greer, Adetola A. Kassim, et al.. (2005). Pegylated filgrastim after high-dose chemotherapy and autologous stem cell transplant. 3. 68–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frédéric Baron Breakdown of academic impact, for papers by Karen K. Ballen Breakdown of academic impact, for papers by Enric Carreras Breakdown of academic impact, for papers by Kirk R. Schultz Breakdown of academic impact, for papers by Marcelo C. Pasquini Breakdown of academic impact, for papers by Christopher Bredeson Breakdown of academic impact, for papers by Yoshiko Atsuta Breakdown of academic impact, for papers by Daniel R. Couriel Breakdown of academic impact, for papers by Dietrich W. Beelen Breakdown of academic impact, for papers by Claudio G. Brunstein
Rankless by CCL
2026